Aller au contenu principal
Accès ouvert déclaré 2025 article

Antioxidant evaluation of novel 3-Aryl-5-phenyloxy-1,2,4-oxadiazoles as radical scavengers: Synthesis, characterization, and ADME studies

2Citations signalées, ce qui n’est pas une note de qualité
7Institutions déclarées
2Pays d’affiliation déclarés

Rattachement africain : sa, Égypte. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Cell function depends on redox homeostasis, and several diseases are linked to its disruption. The relative amounts of reduced and oxidised glutathione play a major role in controlling redox balance. Redox equilibrium is essential for a number of physiological functions, including protein folding and cell signalling. Thus, redox imbalance has been linked to a number of clinical illnesses, including diabetes, cancer, and neurodegenerative diseases. Here, we designed and synthesized a new library of 3, 5-diaryl-1,2,4-oxadiazole derivatives, evaluated by scavenging the dangerous free radicals. The produced oxadiazoles are all examined by spectroscopic and micro-analytical techniques. Three assays were used to assess the antioxidant properties: total antioxidant (FRAP), DPPH (2,2-diphenyl-1-picrylhydrazyl) radicals, and nitric oxide. When nitric oxide, DPPH, and FRAP were combined, the results were nearly same. Key findings revealed that compounds 12 , 10 , and 13 exhibited superior NO scavenging activity with IC 50 values of 35.59 ± 1.3, 37.41 ± 1.1, and 40.54 ± 1.3 μM, respectively. DPPH assay results indicated potent radical scavenging activity, with IC 50 values of 67.08 ± 1.1 to 99.94 ± 1.1 μM. In the FRAP assay, compounds 15 , 18 , 11 , 10 , and 12 demonstrated the highest antioxidant activities, which were consistent with the results of the other assays. Computational predictions of the physicochemical attributes, pharmacokinetic profiles, and drug-likeness data of all the synthesized compounds indicated that our hits may be introduced as drug-like candidates because they showed appropriate criteria in medicinal chemistry and drug-likeness values which hopefully can alleviate poor biopharmaceutical properties of many antioxidants.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Antioxidant evaluation of novel 3-Aryl-5-phenyloxy-1,2,4-oxadiazoles as radical scavengers: Synthesis, characterization, and ADME studies
Date Crossref
01/07/2025
Éditeur
Elsevier BV
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Free Radicals and AntioxidantsSynthesis and biological activityComputational Drug Discovery Methods

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.